Aberrant activity in retinal degeneration impairs central visual processing and relies on Cx36-containing gap junctions Academic Article uri icon


MeSH Major

  • Connexins
  • DNA
  • Gap Junctions
  • Mutation
  • Retinal Degeneration
  • Retinal Rod Photoreceptor Cells
  • Vision, Ocular


  • In retinal degenerative disease (RD), the diminished light signal from dying photoreceptors has been considered the sole cause of visual impairment. Recent studies show a 10-fold increase in spontaneous activity in the RD network, challenging this paradigm. This aberrant activity forms a new barrier for the light signal, and not only exacerbates the loss of vision, but also may stand in the way of visual restoration. This activity originates in AII amacrine cells and relies on excessive activation of gap junctions. However, it remains unclear whether aberrant activity affects central visual processing and what mechanisms lead to this excessive activation of gap junctions. By combining genetic manipulation with electrophysiological recordings of light-induced activity in both living mice and isolated wholemount retina, we demonstrate that aberrant activity extends along retinotectal projections to alter activity in higher brain centers. Next, to selectively eliminate Cx36-containing gap junctions, which are the primary type expressed by AII amacrine cells, we crossed rd10 mice, a slow-degenerating model of RD, with Cx36 knockout mice. We found that retinal aberrant activity was reduced in the rd10/Cx36KO mice compared to rd10 controls, a direct evidence for involvement of Cx36-containing gap junctions in generating aberrant activity in RD. These data provide an essential support for future experiments to determine if selectively targeting these gap junctions could be a valid strategy for reducing aberrant activity and restoring light responses in RD.

publication date

  • March 26, 2015



  • Academic Article



  • eng

PubMed Central ID

  • PMC4655183

Digital Object Identifier (DOI)

  • 10.1016/j.exer.2015.05.013

PubMed ID

  • 26005040

Additional Document Info